St. Joseph Hospital of Orange
1100 West Stewart Dr, Orange, CA 92868714.633.9111
About Us News Room Careers Contact Us
Find St. Joseph Hospital Services Our Doctors Our Services For Patients For Visitors For Community
Liver Tumor Program
Liver, Bile Duct and Pancreas Tumor Program
Our Experts
Meet Our Patient Navigator
About Liver Cancer
Clinical Services
Radiology/Imaging
Surgery
Endoscopic Evaluation
Medical Oncology
Multidisciplinary Treatments
Radiation Oncology
Clinical Trials
Liver Tumor Program Brochure
Glossary of Terms
Patient and Family Resources
Publications
Liver Tumor Program Fund

Share this page:

Facebook
Twitter
Google +

Liver Tumor Publications

Holt A, Wagman LD, Senthil M, et al.: Transarterial Radioembolization with Yttrium-90 for Regional Management of Hepatocellular Cancer: The Early Results of a Nontransplant Center. Am Surg 2010 Oct;76(10):1079-83.

Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010 Mar1;116(5):1367-77.

Alberts SR, Roh MS, Mahoney MR, O'Connell MJ, Nagorney DM, Wagman LD, Smyrk TC, Weiland TL, Lai LL, Schwarz RE, Molina R, Dentchev T, Bolton JS. Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-6 J Clin Oncol. 2010 Feb 10;28(5):853-8. Epub 2010 Jan 4.

Wagman LD, Byun TE . Managing colorectal cancer liver metastases. Oncology 2009;23(12):1063-71.

Wagman LD, Lee B, Castillo E, El-Bayar H, Lai L. Liver Resection Using a Four-Prong Radiofrequency Transection Device. The American Surgeon Oct 2009;75(10):991-994..

Huang W, Wagman LD. FXR regulates liver repair after CCL4-induced toxic injury. Mol Endocrinol . 2010 May;24(5):886-97. Epub 2010 Mar 8.

Mailey, B, Truong, C, Artinyan, A, Khalili, J, Sanchez-Luege, N, Denitz, J, Marx, H, Wagman LD, Kim, J. Surgical Resection of Primary and Metastatic Hepatic Malignancies following Portal Vein Embolization. J Surg Oncol. 2009 Sep 1:100(3):184-90.

Yen Y, Lim DW, Chung V, Morgan RJ, Leong LA, Shibata SI, Wagman LD, et al. Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial. Am J Clin Oncol. 2008 Aug;31(4):317-22.

Artinyan A, Nelson R, Soriano P, Chung V, Retseck J, Reynolds J, Marx H, Kim J, Wagman LD. Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB 2008;10:396-404.

Wagman LD, Kim J. Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization. (Submitted 2009)

Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD, Hellinger JC, Kang BC. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol 2008 Jan;23(1):95-101.

Sun V, Ferrell B, Juarez G, Wagman LD, Yen Y, Chung V. Symptom concerns and quality of life in hepatobiliary cancers. Oncology Nursing Forum 2008: Online. 35(3):E45-52.

Wagman LD. Expanded criteria for surgery for liver metastases: thoughtful science or diamond mining?[comment]. Journal of Clinical Oncology 2008: 26(22):3663-4.

Alberts, Steven R,Wagman LD. Chemotherapy for colorectal Cancer Liver Metastases. The Oncologist 2008: 1063-1073

Feliberti EC, Nelson RA, Wagman LD. Radiofrequency ablation of small hepatic malignancies provides local control equal to resection. AHPBA Meeting, April 2007.

Ha BY, Ahmed A, Sze DY, Razavi MK, Simpson N, Keeffe EB, Nguyen MH. Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther 2007 Sep;15:26(6):839-46.

Wagman LD. More tools, new strategies: Enlarging the therapeutic scope for the patient with liver metastases from colorectal cancer. J Surg Onc 2007;95(1):1-3.

Feliberti E, Wagman LD. Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control.2006;13(1):48-51.

Roybal JJ, Feliberti EC, Rouse L, Wagman LD. Pump removal in infected patients with hepatic chemotherapy pumps: when is it necessary? Am Surg 2006;72(10):880-884.

Benson AB 3rd, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Wagman LD et al. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Can Netw 2006;4(8):728-750.

Hsu CP, Razavi MK, So SK, Parachikov IH, Benaron DA. Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. J Vasc Interv Radiol 2005 Nov;16(11):1473-8.

Faynsod M, Wagman LD, Longmate J, Carroll M, Leong LA. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy. J Clin Oncol 2005;23(22):4876-4880.

Podnos YD, Wagman LD. Surgical management of hepatic breast cancer metastases. Oncology 2005;19(12):1583-7.

Razavi MK. Complications of RF Ablation: An invited commentary. Radiographics 2003 Jan-Feb;23(1):134-6

Kim P, Prapong W, Sze DY, So SK, Razavi MK. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol 2002 Sep;5(3):127-31

Sze D, Razavi MK, So SKS, Jeffrey RB. Impact of the use of multi-detector CT hepatic arteriography on the planning of chemoembolization treatment for hepatocellular carcinoma. AJR Am J Roentgenol 2001;177:1339-1345.

Wagman LD, Pigazzi A. Hepatic artery infusion: Robotic assisted pump placement. In: International Principles of Lap Surg (In Press)